CRLBF
Cresco Labs Inc.
$0.79
+0.02 (+2.06%)
At close · Jul 8
Market Cap
$293.06M
Shares
354,225,583
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.79
Open$0.75
Day$0.75–0.81
52W$0.48–2.30
Avg vol 30d382K
Short int921K · 0.3% float · 1.0d
Short vol46%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−24%
below
Price vs 50-day avg
−13%
below
RSI (14)
45
neutral
MACD trend
Positive
52-week position
17%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−17%
trailing
6-month return
−40%
trailing
YTD return
−36%
this year
Relative strength
−48%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
2 of 9 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.26% of float · ▲ +28.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 4-yr range
Squeeze score
16
low risk · 0–100
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
49%
contracting
EPS growth
−73%
Y/Y
Free cash flow
$37.8M
Balance sheet
$57.9M
net cash
Quant / Vol
risk profile
Volatility
150%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
8.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−24%
Bearish
Price vs 50-day avg
−13%
Bearish
RSI (14)
45
Neutral
MACD trend
Positive
Bullish
52-week position
17%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
2 of 9 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.26% of float · ▲ +28.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 4-yr range
Price context
position in its 52-week range
52-wk low $0
Now $1 · 17%
52-wk high $2
vs 200-day avg -24%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRLBF
this stock
Cresco Labs Inc.
|
$293.06M | -35.7% | -9.5% | — | 0.3% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.49B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.94B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
9
- % held
- 0.1%
- Reported
- 2 of 9
- Top holder
- First National Trust Co
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRLBF | -4.7% | -16.7% | -40.1% | -4.7% | -35.7% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -4.5% | -17.6% | -47.5% | -4.5% | -45.0% |